Boston Scientific Announces Six ICD/CRT-D Approvals
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific announced FDA approval of the Dynagen Mini and Inogen Mini ICDs, which it claims are the thinnest and smallest ICDs available, and the Dynagen X4 and Inogen X4 quadripolar CRT-Ds.
You may also be interested in...
Boston Scientific Will Lean On Quadripolar, S-ICD To Revive Sagging U.S. CRM Sales
Boston Scientific reported disappointing first-quarter results for its cardiac rhythm management division, mostly due to price erosion in the U.S and the lack of a quadripolar CRT-D device. But the firm argues that the new S-ICD and forthcoming quadripolar CRT-D products may help turn the business around soon.
News Briefs: Siemens-Pfizer Dx Pact; Pancreatic Stent; AtriCure Acquisition
Siemens teams with Pfizer on companion Dx. XLumena gains pancreatic stent approval. AtriCure acquires Estech. More news.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.